Metabolism of ropivacaine in humans is mediated by CYP1A2 and to a minor extent by CYP3A4: An interaction study with fluvoxamine and ketoconazole as in vivo inhibitors*
Arlander, Eva, Ekström, Gunilla, Alm, Christina, Carrillo, Juan Antonio, Bielenstein, Margareta, Böttiger, Ylva, Bertilsson, Leif, Gustafsson, Lars L.Volume:
64
Language:
english
Pages:
8
Journal:
Clinical Pharmacology & Therapeutics
DOI:
10.1016/s0009-9236(98)90131-x
Date:
November, 1998
File:
PDF, 896 KB
english, 1998